Perbedaan Bank Multiarta Sentosa Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Bank Multiarta Sentosa Tbk. diperdagangkan di Rp3.360 (kapitalisasi pasar 4,7 T, volume 24 jam 10 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Bank Multiarta Sentosa Tbk. jauh lebih besar — sekitar 28,3× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (324 rb vs 10 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MASB | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 4,7 T | 166,01 M |
Volume | 10 rb | 324 rb |
Lot | 100 | 3,24 rb |
Perputaran | 33,47 jt | 77,68 jt |
Harga Rata-rata | 3.347 | 239,75 |
Nilai Transaksi | 33,47 jt | 77,68 jt |
Harga Ekuilibrium Indikatif | 3.230 | 240 |
Volume Ekuilibrium Indikatif | 10 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Bank Multiarta Sentosa Tbk (the Bank) was established by Deed No.201 dated July 28, 1992 of H.Saidus Sjahar, S.H. The Bank's parent company is PT Danabina Sentana which is the majority stockholder of the Bank. The majority shareholder of PT Danabina Sentana is PT Lumbung Artakencana which is a company established in Indonesia and the Bank’s ultimate shareholder that joined in business group of Wings Group.
Selengkapnya di halaman MASB →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →